First Clinical Trial of AI Therapy Chatbot Shows Promising Mental Health Outcomes

A recent clinical trial by Dartmouth researchers found that Therabot, a generative AI-powered therapy chatbot, significantly reduced symptoms of depression, anxiety, and eating disorders. Participants reported improvements comparable to traditional therapy, highlighting Therabot’s potential to expand access to mental health support. However, researchers emphasize the need for clinician oversight.

Dartmouth College

A groundbreaking Dartmouth-led study has found that Lumen, a voice-based therapy chatbot, can significantly reduce symptoms of anxiety and depression. As the first randomized clinical trial of its kind, the research highlights the potential of AI to expand access to effective mental health care.


Read the original article.

Share this post

The views shared are those of the authors and do not necessarily reflect those of eMHIC. This content is for general informational or educational purposes only and is not a substitute for professional mental health advice, diagnosis, or treatment. If you are experiencing a mental health crisis, please immediately contact local emergency services or a crisis support service in your area.
For more details, see our Privacy Policy & Terms of Service